Market cap
$14 Mln
Revenue (TTM)
$71 Mln
P/E Ratio
--
P/B Ratio
7.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-6.9 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-12.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-8.6
-
Face value
--
-
Shares outstanding
6,244,940
8 Years Aggregate
CFO
$-334.07 Mln
EBITDA
$-320.76 Mln
Net Profit
$-435.07 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vapotherm (VAPO)
| 117.0 | 0.9 | 1.9 | -33.2 | -78.8 | -51.2 | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|
|
Vapotherm (VAPO)
| -95.4 | -87.0 | -22.9 | 120.9 | -39.0 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Vapotherm (VAPO)
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and... internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Read more
-
CEO, President & Director
Mr. Joseph F. Army CPA
-
Senior VP, CFO & Treasurer
Mr. John Landry
-
Headquarters
Exeter, NH
-
Website
FAQs for Vapotherm (VAPO)
What is the current share price of Vapotherm Inc (VAPO) Today?
The share price of Vapotherm Inc (VAPO) is $2.17 (NYSE) as of 19-Sep-2024 15:20 EDT. Vapotherm Inc (VAPO) has given a return of -78.8% in the last 3 years.
What is the current PB & PE ratio of Vapotherm Inc (VAPO)?
Since, TTM earnings of Vapotherm Inc (VAPO) is negative, P/E ratio is not available.
The P/B ratio of Vapotherm Inc (VAPO) is 7.11 times as on 19-Sep-2024, a 85 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.10 |
-0.11 |
2022 |
-0.08 |
-0.33 |
2021 |
-1.13 |
1.01 |
2020 |
-1.53 |
0.76 |
2019 |
-0.62 |
0.59 |
What is the 52 Week High and Low of Vapotherm Inc (VAPO)?
The 52-week high and low of Vapotherm Inc (VAPO) are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of Vapotherm Inc (VAPO)?
Vapotherm Inc (VAPO) has a market capitalisation of $ 14 Mln as on 19-Sep-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Vapotherm Inc (VAPO)?
Before investing in Vapotherm Inc (VAPO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.